Cardiotoxicidad de los Quimioterapéuticos Tipo Antraciclinas de la Lista Oficial de Medicamentos de la Caja Costarricense del Seguro Social.
保存先:
| 著者: | , |
|---|---|
| フォーマット: | artículo original |
| 状態: | Versión publicada |
| 出版日付: | 2018 |
| その他の書誌記述: | Cardiotoxicity associated with the use of chemotherapy has been largely corroborated through multiple clinical trials. In Costa Rica, the development of Cardio-oncologic Units has begun recently in various medical centers with the purpose of achieving an early detection of the deleterious cardiovascular effect associated with different chemotherapeutics. This review consists of a summary of the clinical manifestations related to the use of anthracyclines available in the Costa Rican public health system. |
| 国: | Portal de Revistas UCR |
| 機関: | Universidad de Costa Rica |
| Repositorio: | Portal de Revistas UCR |
| 言語: | Español |
| OAI Identifier: | oai:portal.ucr.ac.cr:article/36062 |
| オンライン･アクセス: | https://revistas.ucr.ac.cr/index.php/clinica/article/view/36062 |